- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by C3i Center Inc.
Total 4909 results
-
Memorial Sloan Kettering Cancer CenterSpectrum Pharmaceuticals, IncActive, not recruitingMultiple Myeloma | AmyloidosisUnited States
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia (CLL) | Refractory | RelapsedUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.; AmgenCompleted
-
Memorial Sloan Kettering Cancer CenterBeyondSpring Pharmaceuticals Inc.Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterClovis Oncology, Inc.Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterAragon Pharmaceuticals, Inc.Completed
-
M.D. Anderson Cancer CenterAstex Pharmaceuticals, Inc.; PharmatechCompleted
-
M.D. Anderson Cancer CenterArchimedes Pharma US, Inc.Terminated
-
Endomagnetics IncM.D. Anderson Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
M.D. Anderson Cancer CenterMyriad Genetic Laboratories, Inc.Withdrawn
-
M.D. Anderson Cancer CenterGenentech, Inc.; OSI PharmaceuticalsCompletedChronic Lymphocytic LeukemiaUnited States
-
University of Michigan Rogel Cancer CenterGenentech, Inc.TerminatedLoco-regional Esophageal Cancer
-
M.D. Anderson Cancer CenterTAP Pharmaceutical Products Inc.CompletedAmenorrhea | Premature Ovarian Failure | Ovarian Function InsufficiencyUnited States
-
University of Michigan Rogel Cancer CenterGenentech, Inc.CompletedHER-2 Positive Metastatic Breast CancerUnited States
-
M.D. Anderson Cancer CenterBayer; Astex Pharmaceuticals, Inc.Terminated
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; American Cancer Society, Inc.Completed
-
M.D. Anderson Cancer CenterAscentage Pharma Group Inc.Not yet recruitingAdvanced Chronic Myeloid Leukemia | Philadelphia Chromosome-Positive Acute Myeloid LeukemiaUnited States
-
Daynamica, Inc.Masonic Cancer Center, University of MinnesotaNot yet recruiting
-
M.D. Anderson Cancer CenterSanofi US Services, IncRecruiting
-
M.D. Anderson Cancer CenterBioMed Valley Discoveries, IncRecruiting
-
Abramson Cancer Center at Penn MedicineGenentech, Inc.RecruitingDLBCL - Diffuse Large B Cell Lymphoma | Large B-cell LymphomaUnited States
-
Abramson Cancer Center at Penn MedicineGenentech, Inc.Recruiting
-
Seres Therapeutics, Inc.Memorial Sloan Kettering Cancer CenterActive, not recruitingAllogeneic Hematopoietic Stem Cell TransplantationUnited States
-
Memorial Sloan Kettering Cancer CenterIovance Biotherapeutics, Inc.Active, not recruiting
-
Fox Chase Cancer CenterCelgene Corporation; Seagen Inc.Active, not recruitingCutaneous T-cell Lymphoma (CTCL)United States
-
M.D. Anderson Cancer CenterAstraZeneca; Mirati Therapeutics Inc.WithdrawnLung Cancer | Gastro-intestinal CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Genentech, Inc.CompletedNon-small Cell Lung Cancer | EGFR-mutant Lung CancersUnited States
-
Dartmouth-Hitchcock Medical CenterAmerican Cancer Society, Inc.CompletedCommunicationUnited States
-
Memorial Sloan Kettering Cancer CenterContext Therapeutics Inc.WithdrawnMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
TG Therapeutics, Inc.Memorial Sloan Kettering Cancer CenterCompletedChronic Lymphocytic Leukemia | Richter SyndromeUnited States
-
TG Therapeutics, Inc.James P. Wilmot Cancer CenterTerminatedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterSamus Therapeutics, Inc.CompletedMetastatic Breast CancerUnited States
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.; Aventis PharmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Genentech, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedAmyloidosis | Light Chain Deposition Disease (LCDD or MIDD) | Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD) | Monoclonal Immunoglobulin Deposition Disease (MIDD)United States
-
M.D. Anderson Cancer CenterCelgene; Onyx Therapeutics, Inc.Terminated
-
Dartmouth-Hitchcock Medical CenterAmerican Cancer Society, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterSchering-Plough; Eisai Inc.TerminatedMelanomaUnited States
-
The New York Eye Cancer CenterGenentech, Inc.Completed
-
Rush University Medical CenterAmerican Cancer Society, Inc.CompletedColorectal Cancer ScreeningUnited States
-
The New York Eye Cancer CenterGenentech, Inc.CompletedRadiation RetinopathyUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.; Aventis PharmaceuticalsCompletedHead and Neck CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAmbrilia Biopharma, Inc.CompletedProstate CancerUnited States
-
Jonsson Comprehensive Cancer CenterGlaxoSmithKline; Novartis; Astellas Pharma Inc; Prostate Cancer Foundation; Medivation...Active, not recruitingProstate CancerUnited States
-
Education Development Center, Inc.Completed
-
Envita Medical Center, Inc.SuspendedGlioma | Breast Cancer | Pancreatic Cancer | Prostate Cancer | Colon Cancer | Hepatocellular Cancer | Squamous Cell Lung CancerUnited States
-
Dartmouth-Hitchcock Medical CenterAmerican Cancer Society, Inc.RecruitingBreast CancerUnited States
-
University of Michigan Rogel Cancer CenterGenentech, Inc.Not yet recruitingSecondary Acute Myeloid LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterIovance Biotherapeutics, Inc.RecruitingMelanoma | Metastatic Melanoma | Metastatic Uveal Melanoma | Uveal MelanomaUnited States